ssm.sarafimaskan.org Open in urlscan Pro
2606:4700:3035::6815:4de8  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main content

We use cookies that are necessary to make our site work. We may also use
additional cookies to analyze, improve, and personalize our content and your
digital experience. For more information, see our Cookie Policy.

Accept all cookies
Cookie settings


Unfortunately we don't fully support your browser. If you have the option to,
please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google
Chrome, or Safari 14 or newer. If you are unable to, and need support, please
send us your feedback.

Dismiss

We'd appreciate your feedback on this new experience.Tell us what you
think(opens in new tab/window)

 * Academic & GovernmentAcademic & Government
 * HealthHealth
 * IndustryIndustry
 * Elsevier ConnectInsights
 * AboutAbout
 * Support centerSupport

Publish with us
Open Search
Shopping Cart
Location Selector
User account
Show Menu

FOR THE BENEFIT

OF SOCIETY



We help researchers and healthcare professionals advance science and improve
healthcare outcomes.

 * 
   Discover Complete HeartX
 * 
   Discover Scopus AI
 * 
   Hear from library leaders
 * 
   Discover ClinicalKey AI
 * 
   Hear from academic leaders

Slide
Slide

I want to...

Publish with Elsevier
Find a journal article
Discover products
Shop books & journals
Find a job



PRODUCTS AND SERVICES FOR INFORMED DECISIONS

Academic & Government

Health

Industry


ADVANCING RESEARCH FOR THE BENEFIT OF SOCIETY

To support researchers, librarians, research leaders and funders, we curate and
enrich research with high-quality data and analytics and help customers address
challenges at every stage of the research journey.

From researcher tools to research management and evaluation solutions, learn how
we can help you improve productivity and amplify research impact.

Explore Academic & Government



INSIGHTS FOR BETTER OUTCOMES

UNLOCKING AI FOR R&D

Discover 10 tips from four of our AI experts
Learn more


CONNECT

Elsevier and Every Cure: treating rare diseases with generic drugs — at scale


CONNECT

Repurposing drugs for rare diseases, cancer and beyond


CONNECT

New challenges lead R&D companies to look beyond their specialties


FEATURED TOPICS AND COMMUNITIES

Sustainability
Open science
Gender & Diversity
Healthcare & Medicine
Research leadership
Data & Analytics
Researchers
Librarians

CAREERS AT ELSEVIER

We're building a great workplace culture at Elsevier where amazing people, like
you and others, can do purposeful work, grow every day and work with colleagues
who care.

Explore careers at Elsevier
Play


DISCOVER MORE ABOUT ELSEVIER

 * 
   Connect
   ELSEVIER NAMED BEST COMPANY FOR DIVERSITY

 * 
   Connect
   ELSEVIER RANKED #2 WORLDWIDE FOR WORK-LIFE BALANCE

 * 
   Connect
   OUR JOURNEY WITH RARE DISEASES GIVES EVEN MORE MEANING TO MY WORK AT ELSEVIER

 * 
   Connect
   ELSEVIER CEO KUMSAL BAYAZIT SHINES AS #2 BEST CEO FOR WOMEN

 * 
   Connect
   ELSEVIER NAMED A TOP COMPANY FOR GLOBAL CULTURE AND COMPANY OUTLOOK

 * 
   Connect
   WOMEN’S EMPOWERMENT IS A REALITY AT ELSEVIER — HERE’S MY EXPERIENCE

 * 
   Connect
   ELSEVIER NAMED A TOP COMPANY FOR CAREER GROWTH

Slide
Slide

USEFUL LINKS

 * Submit your paper(opens in new tab/window)
 * Shop Books & Journals(opens in new tab/window)
 * Open access(opens in new tab/window)
 * View all products(opens in new tab/window)
 * Elsevier Connect(opens in new tab/window)

SUPPORT

 * Resource center(opens in new tab/window)
 * Customer support(opens in new tab/window)

ABOUT

 * About Elsevier(opens in new tab/window)
 * Careers(opens in new tab/window)
 * Newsroom(opens in new tab/window)
 * Advertising, reprints & supplements(opens in new tab/window)

Global | English

(LinkedIn opens in new tab/window)(Twitter opens in new tab/window)(Facebook
opens in new tab/window)(YouTube opens in new tab/window)
(opens in new tab/window)(opens in new tab/window)

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are
reserved, including those for text and data mining, AI training, and similar
technologies.

 * Terms & Conditions(opens in new tab/window)
 * Privacy policy(opens in new tab/window)
 * Accessibility(opens in new tab/window)
 * Cookie settings